WILMINGTON, Del., May 31, 2023 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Prelude) PRLD, a clinical-stage precision oncology company, announced today that the company will participate in the Jefferies Healthcare Conference, taking place in New York City, June 7 to 9, 2023. Details are as follows: On Wednesday, June 7th, at…Read More
Prelude Therapeutics To Participate in Jefferies Healthcare Conference Prelude Therapeutics NASDAQPRLD
